Details of the Drug
General Information of Drug (ID: DM8HWS9)
Drug Name |
P-Anisic Acid
|
||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Synonyms |
4-METHOXYBENZOIC ACID; p-Anisic acid; 100-09-4; ANISIC ACID; p-Methoxybenzoic acid; Draconic acid; 4-Anisic acid; Benzoic acid, 4-methoxy-; ANISIC ACID, PARA; para-anisic acid; Anisic acid, p-isomer; 4-methoxy-benzoic acid; Kyselina 4-methoxybenzoova; UNII-4SB6Y7DMM3; P-Methoxy Benzoic Acid; 4-Methoxy benzoic acid; Methoxybenzoic acid; Kyselina 4-methoxybenzoova [Czech]; EINECS 202-818-5; NSC 32742; 1335-08-6; BRN 0508910; 4SB6Y7DMM3; AI3-00893; CHEBI:40813; ZEYHEAKUIGZSGI-UHFFFAOYSA-N; p-methoxybenzoate; p-Anisic acid, 98%
|
||||||||||||||||||||||
Indication |
|
||||||||||||||||||||||
Drug Type |
Small molecular drug
|
||||||||||||||||||||||
Structure | |||||||||||||||||||||||
3D MOL | 2D MOL | ||||||||||||||||||||||
#Ro5 Violations (Lipinski): 0 | Molecular Weight (mw) | 152.15 | |||||||||||||||||||||
Logarithm of the Partition Coefficient (xlogp) | 2 | ||||||||||||||||||||||
Rotatable Bond Count (rotbonds) | 2 | ||||||||||||||||||||||
Hydrogen Bond Donor Count (hbonddonor) | 1 | ||||||||||||||||||||||
Hydrogen Bond Acceptor Count (hbondacc) | 3 | ||||||||||||||||||||||
Chemical Identifiers |
|
||||||||||||||||||||||
Cross-matching ID | |||||||||||||||||||||||
Molecular Interaction Atlas of This Drug
Drug Therapeutic Target (DTT) |
|
||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Molecular Interaction Atlas (MIA) | |||||||||||||||||||||||||||
Molecular Expression Atlas of This Drug
The Studied Disease | Discovery agent | |||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
ICD Disease Classification | N.A. | |||||||||||||||||||||||
|
||||||||||||||||||||||||
Molecular Expression Atlas (MEA) | ||||||||||||||||||||||||